did not outshine standard treatment with second generation drug-eluting stents (DES) as they were expected to, in a surprise finding of the first randomized trial to compare clinical outcomes in ...

Background: The drug-eluting stents have decreased the incidence of instent restenosis compared to bare metal stents. But, the incidence of late and very late stent thrombosis has increased with ...

The DynamX Bioadaptor device was noninferior to DES for TLF overall, but a landmark analysis reveals a potential strength.

In order to overcome the problem of ST encountered with first-generation DES ... utilizing 'pro-healing' substances not eluted by the stent, but which attract endothelial cells, may reduce ...

A bioresorbable vascular scaffold (BRS) with highly aligned microstructure and small-crystallite crystallinity can avoid high ...

Abbott's Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit™ BTK System) offers a new ... stent in the UAE for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK).

UAE - Al Qassimi Hospital has successfully implanted the first Esprit BTK Everolimus Eluting ... dissolvable stent in the UAE for people with chronic limb-threatening ischemia (CLTI) below-the-knee ...

Esprit™ BTK is a first-of-its-kind dissolvable stent in the UAE for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). Approved by the U.S. Food and Drug Administration ...

Undergoing percutaneous coronary intervention (PCI) for narrowed arteries with a novel bioadaptor is at least as effective as a contemporary drug-eluting ... generation DES and bare metal stents.